Zeria Pharmaceutical Co Ltd
TSE:4559
Zeria Pharmaceutical Co Ltd
EPS (Diluted)
Zeria Pharmaceutical Co Ltd
EPS (Diluted) Peer Comparison
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zeria Pharmaceutical Co Ltd
TSE:4559
|
EPS (Diluted)
¥175
|
CAGR 3-Years
37%
|
CAGR 5-Years
20%
|
CAGR 10-Years
5%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
EPS (Diluted)
¥92
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-4%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
EPS (Diluted)
¥104
|
CAGR 3-Years
39%
|
CAGR 5-Years
17%
|
CAGR 10-Years
2%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
EPS (Diluted)
¥253
|
CAGR 3-Years
-4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
-1%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
EPS (Diluted)
¥198
|
CAGR 3-Years
16%
|
CAGR 5-Years
27%
|
CAGR 10-Years
6%
|
|
Astellas Pharma Inc
TSE:4503
|
EPS (Diluted)
¥9
|
CAGR 3-Years
-47%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
-14%
|
See Also
What is Zeria Pharmaceutical Co Ltd's EPS (Diluted)?
EPS (Diluted)
175.4
JPY
Based on the financial report for Mar 31, 2024, Zeria Pharmaceutical Co Ltd's EPS (Diluted) amounts to 175.4 JPY.
What is Zeria Pharmaceutical Co Ltd's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
5%
Over the last year, the EPS (Diluted) growth was 25%. The average annual EPS (Diluted) growth rates for Zeria Pharmaceutical Co Ltd have been 37% over the past three years , 20% over the past five years , and 5% over the past ten years .